There are 2789 resources available
898P - Locoregional vs. distant relapse: Impact on survival in patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immunotherapy
Presenter: Emily Alouani
Session: ePoster Display
899P - Gene expression analysis of primary and recurrent laryngeal tumors reveals disruption in key regulatory pathways
Presenter: Nikol Mladkova
Session: ePoster Display
Resources:
Abstract
820TiP - ENGOT-EN6/GOG-3031/NSGO-CTU-RUBY part 2: A phase III, randomized, double-blind, study of dostarlimab + carboplatin-paclitaxel followed by dostarlimab + niraparib versus placebo (PBO) + carboplatin-paclitaxel followed by PBO in recurrent or advanced endometrial cancer (EC)
Presenter: Mansoor Raza Mirza
Session: ePoster Display
821TiP - GREAT: A multicentric cohort of advanced ovarian cancer (AOC) treated in real life with prospective collection of clinical data, tumor sample, and biomarkers (tBRCA, HRD) including genomic putative theranostic markers: A GINECO study
Presenter: Thibault De La Motte Rouge
Session: ePoster Display
822TiP - BFR ESS: A randomized phase II trial from the GSF/GETO French group evaluating the impact of interruption versus maintenance of aromatase inhibitors in patients with advanced or metastatic low grade endometrial stromal sarcoma after at least 3 years of therapy
Presenter: Isabelle Ray-Coquard
Session: ePoster Display
Resources:
Abstract
905P - FIH phase I dose escalation and dose expansion study of anti-EGFR ADC MRG003 in patients with advanced solid tumors
Presenter: Miaozhen Qiu
Session: ePoster Display
840P - Preliminary phase I/II study results of orelabrutinib combined with MIL62 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma
Presenter: Yuan-Kai Shi
Session: ePoster Display
841P - IGM-2323 is a CD20xCD3 IgM bispecific T-cell engager that kills low CD20-expressing and rituximab-resistant B-cell lymphomas
Presenter: Keyu Li
Session: ePoster Display
907P - Ribociclib and spartalizumab for head and neck squamous cell carcinoma: A phase I study with expansion cohort
Presenter: Hsiang-Fong Kao
Session: ePoster Display